We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

52 hedge funds and large institutions have $16M invested in Perspective Therapeutics in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $9.99M → $16M (+$6.03M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

6% more funds holding

Funds holding: 49 → 52 (+3)

0% more ownership

Funds ownership: 1.3% → 1.31% (+0%)

Holders
52
Holders Change
+3
Holders Change %
+6.12%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$450K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$111K
3
HighTower Advisors
HighTower Advisors
Illinois
+$52.1K
4
PIC
Portland Investment Counsel
Ontario, Canada
+$40.1K
5
Morgan Stanley
Morgan Stanley
New York
+$16K

Top Sellers

Rank Fund Capital Flow
1
PCM
Perkins Capital Management
Minnesota
-$555K
2
Jane Street
Jane Street
New York
-$37.7K
3
HF
HRT Financial
New York
-$23.2K
4
TSS
Two Sigma Securities
New York
-$21K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
-$17.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Thrivent Financial for Lutherans
26
Thrivent Financial for Lutherans
Minnesota
$16K – – –
JFG
27
JDM Financial Group
Texas
$14.1K – – –
Two Sigma Advisers
28
Two Sigma Advisers
New York
$13K -$56 -20 -0.6%
SFM
29
Sphera Funds Management
Israel
$10.3K +$7.23K +2,567 New
TWM
30
TMD Wealth Management
Arizona
$8.04K – – –
WAOI
31
Wealth Advisors of Iowa
Iowa
$8.04K – – –
HF
32
HRT Financial
New York
$8K -$23.2K -8,244 -80%
TRCT
33
Tower Research Capital (TRC)
New York
$7.75K +$1.47K +522 +37%
UBS Group
34
UBS Group
Switzerland
$7.32K +$4.93K +1,753 +2,578%
RJFSA
35
Raymond James Financial Services Advisors
Florida
$7.04K – – –
AWM
36
AE Wealth Management
Kansas
$6.79K +$3.05K +1,085 New
Ameriprise
37
Ameriprise
Minnesota
$6.03K – – –
CWM
38
Congress Wealth Management
Massachusetts
$6.03K – – –
MFG
39
Mendota Financial Group
Wisconsin
$6.03K – – –
Jane Street
40
Jane Street
New York
$5.23K -$37.7K -13,379 -91%
GVAG
41
Great Valley Advisor Group
Delaware
$4.82K – – –
AAM
42
Auxier Asset Management
Oregon
$4.11K – – –
CAI
43
Capital Advisors Inc
Oklahoma
$4.02K – – –
JFA
44
JNBA Financial Advisors
Minnesota
$2.01K – – –
Wells Fargo
45
Wells Fargo
California
$1.27K -$8.86K -3,146 -91%
TWC
46
TD Waterhouse Canada
Ontario, Canada
$1.14K – – –
ASN
47
Advisory Services Network
Georgia
$402 +$281 +100 New
JP Morgan Chase
48
JP Morgan Chase
New York
$194 +$42 +15 +45%
Fidelity Investments
49
Fidelity Investments
Massachusetts
$82 -$5.01K -1,780 -99%
Bank of America
50
Bank of America
North Carolina
$67 +$48 +17 New
1
2
3

CATX Hedge Fund Activity: Q4 2023 in Review

52 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2023, worth a combined $16M — up 60% from $9.99M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CATX positions and 8 closed out — a net gain of 3 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $450K. The largest seller was Perkins Capital Management, cutting an estimated $555K.

  • 52 institutional investors held Perspective Therapeutics (CATX) as of Q4 2023, up from 49 in Q3 2023.
  • Funds reported $16M of Perspective Therapeutics stock for Q4 2023, up 60% quarter-over-quarter.
  • 11 funds opened new Perspective Therapeutics positions in Q4 2023 and 8 closed out, a net change of +3 holders.
  • The largest Perspective Therapeutics buyer in Q4 2023 was Ghost Tree Capital, an estimated $450K added.
  • The largest Perspective Therapeutics seller in Q4 2023 was Perkins Capital Management, an estimated $555K sold.

Based on aggregated 13F filings for Q4 2023.